Science Explorer Interactive view Map
Company · Ness Ziona · Israel

Mapi Pharma (Israel)

mapi-pharma.comROR OpenAlex
Research works
33
▲ 59% vs 2013–17
Citations
870
26.4 per fractional work
Top-10% rate
13.0%
record average 16.5%
Open access
45%
world 28%

Not ranked overall: Mapi Pharma (Israel) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.58× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.36× its world share, 0 worksImmunology and Micro…Neuroscience: 2.07× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.75× its world share, 0 worksPharmacology, Toxico…Environmental Science: 0.36× its world share, 0 worksEnvironmental ScienceMedicine: 3.53× its world share, 6 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.8×. Every wedge is a field page.

Which keywords describe research at Mapi Pharma (Israel)?

By fractional works in all years, weighted toward what it does more of than the world: Regeneration, Mesenchymal Stem Cells, Epidemiology, Pathogenesis, Differentiation, Immunomodulation, Multipotent and Genomics.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. Epidemiology5▲ 3.7×20 topics
  2. Regeneration4▲ 62×4 topics
  3. Mesenchymal Stem Cells4▲ 89×2 topics
  4. Oxidative Stress3▲ 4.5×7 topics
  5. Differentiation2▲ 102×2 topics
  6. Pathogenesis2▲ 13×4 topics
  7. Immunomodulation2▲ 48×1 topic
  8. Multipotent2▲ 185×1 topic
  9. Genomics2▲ 19×2 topics
  10. Virus2▲ 56×2 topics
  11. Cancer Immunotherapy2▲ 45×3 topics
  12. H1N12▲ 168×1 topic
  13. Inflammation2▲ 2.6×8 topics
  14. Influenza2▲ 127×1 topic
  15. Immunotherapy2▲ 9.0×6 topics
  16. Innate Immunity2▲ 13×3 topics
  17. Matrix Metalloproteinases1▲ 27×2 topics
  18. Tumor Regression1▲ 45×2 topics
  19. Bioavailability1▲ 22×2 topics
  20. CAR T Cells1▲ 84×1 topic
  21. Cancer Prevention1▲ 16×2 topics
  22. Chimeric Antigen Receptor1▲ 84×1 topic
  23. Nanoparticles1▲ 2.7×6 topics
  24. Neurodegenerative Diseases1▲ 17×2 topics
  25. Antigen Presentation1▲ 32×2 topics
  26. Cartilage1▲ 72×1 topic
  27. Cell Signaling1▲ 9.8×4 topics
  28. Extracellular Matrix1▲ 14×4 topics
  29. Ischemic Stroke1▲ 26×3 topics
  30. Osteoarthritis1▲ 26×1 topic
  31. Antioxidants1▲ 7.1×1 topic
  32. Diagnostic Criteria1▲ 15×2 topics
  33. Free Radicals1▲ 33×1 topic
  34. Gene Therapy1▲ 12×4 topics
  35. Neurodegeneration1▲ 10×5 topics

Which research topics does Mapi Pharma (Israel) publish most on?

By volume in 2022–2025: Mesenchymal stem cell research, CAR-T cell therapy research, Phytochemicals and Antioxidant Activities and Multiple Sclerosis Research Studies.

Mesenchymal stem cell re…1Mesenchymal stem cell research: 1 fractional worksCAR-T cell therapy research: 1 fractional worksPhytochemicals and Antioxidant Activities: 1 fractional worksMultiple Sclerosis Research Studies: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksOsteoarthritis Treatment…0Osteoarthritis Treatment and Mechanisms: 0 fractional worksIon Channels and Receptors: 0 fractional worksIon channel regulation and function: 0 fractional worksAllergic Rhinitis and Sensitization: 0 fractional worksBiopolymer Synthesis and Applications: 0 fractional works
GeneticsOncologyBiochemistryPathology and Forensic Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Mesenchymal stem cell research Genetics 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Phytochemicals and Antioxidant Activities Biochemistry 1 works
  4. 4 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 0 works
  5. 5 RNA Interference and Gene Delivery Molecular Biology 0 works
  6. 6 Osteoarthritis Treatment and Mechanisms Rheumatology 0 works
  7. 7 Ion Channels and Receptors Sensory Systems 0 works
  8. 8 Ion channel regulation and function Molecular Biology 0 works
  9. 9 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
  10. 10 Biopolymer Synthesis and Applications Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.0%not open55.0%

World: 28% of research is openly available.

with international co-authors29.0%domestic only71.0%

World: 19% is written across borders.

How has Mapi Pharma (Israel)'s research output changed?

Output in 2018–2022 was 59% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Ness Ziona

All research institutions in Ness Ziona

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.